United States - English - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - mebendazole (unii: 81g6i5v05i) (mebendazole - unii:81g6i5v05i) - mebendazole 500 mg - vermox™ chewable is indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by ascaris lumbricoides (roundworm) and trichuris trichiura (whipworm). vermox™ chewable is contraindicated in persons with a known hypersensitivity to the drug or its excipients. risk summary the available published literature on mebendazole use in pregnant women has not reported a clear association between mebendazole and a potential risk of major birth defects or miscarriages [see data]. there are risks to the mother and fetus associated with untreated helminthic infection during pregnancy [see clinical considerations] . in animal reproduction studies, adverse developmental effects (i.e., skeletal malformations, soft tissue malformations, decreased pup weight, embryolethality) were observed when mebendazole was administered to pregnant rats during the period of organogenesis at single oral doses as low as 10 mg/kg (approximately 0.2-fold the maximum recommended human dose (mrhd))

United States - English - NLM (National Library of Medicine)

johnson & johnson consumer inc, mcneil consumer healthcare division - mebendazole (unii: 81g6i5v05i) (mebendazole - unii:81g6i5v05i) - mebendazole 100 mg - vermox™ is indicated for the treatment of patients two years of age and older with gastrointestinal infections caused by ancylostoma duodenale (hookworm), ascaris lumbricoides (roundworm), enterobius vermicularis (pinworm), necator americanus (hookworm), and trichuris trichiura (whipworm). vermox™ is contraindicated in persons with a known hypersensitivity to the drug or its excipients. risk summary the available published literature on mebendazole use in pregnant women has not reported a clear association between mebendazole and a potential risk of major birth defects or miscarriages [see data]. there are risks to the mother and fetus associated with untreated helminthic infection during pregnancy [see clinical considerations] . in animal reproduction studies, adverse developmental effects (i.e., skeletal malformations, soft tissue malformations, decreased pup weight, embryolethality) were observed when mebendazole was administered to pregnant rats during the period of organogenesis at single oral dose

Israel - English - Ministry of Health

j-c health care ltd - mebendazole - suspension - mebendazole 20 mg/ml - mebendazole - mebendazole - treatment of single or mixed infections of trichuris trichura (whipworm), ascaris lumbricoides (large roundworm), ancylostoma duodenale, necator americanus (hookworm), strongyloides stercoralis, enterobius vermicularis (threadworm/pinworm) and taenia spp.

Israel - English - Ministry of Health

j-c health care ltd - mebendazole - tablets - mebendazole 100 mg - mebendazole - mebendazole - treatment of trichuris trichiura (whipworm). ascaris lumbricoides (roundworm). ancylostoma duodenale (common hookworm). necator americanus (american hookworm), strongyloidiasis, enterobius vermicularis (pinworm) and teniasis in single or mixed infections.

Malta - English - Medicines Authority

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - mebendazole - tablet - mebendazole 100 mg - anthelmintics

Malta - English - Medicines Authority

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - mebendazole - oral suspension - mebendazole 20 mg/ml - anthelmintics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - mebendazole - chewable tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - mebendazole - oral suspension - 20mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - mebendazole - tablet - 100 milligram(s) - benzimidazole derivatives; mebendazole

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - mebendazole - oral suspension - 100 mg/5ml - benzimidazole derivatives; mebendazole